ClinConnect ClinConnect Logo
Search / Trial NCT06443801

Efficacy Of Web-based Breastfeeding Education

Launched by NURDAN DEMIRCI · May 30, 2024

Trial Information

Current as of November 06, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is testing whether a four‑module online education program about breastfeeding, started during pregnancy, helps first‑time mothers feel more confident about breastfeeding, have a more positive view of breastfeeding, and worry less about whether they have enough milk after birth. It’s a randomized trial, which means participants are put into one of two groups by chance: one group will get the web education during pregnancy, and the other group will not. About 90 healthy women pregnant with their first baby, who are 24–36 weeks along, will take part. They must be able to speak Turkish, have at least a primary school education, and have a computer or smartphone they can use. Participants will not know which group they are in.

If you join the education group, you’ll complete four online modules during pregnancy. All participants will complete surveys around pregnancy and then again after birth at about 7 days, 3 months, and 6 months. The researchers will look at how you feel about breastfeeding, whether you show signs of postpartum depression, how you perceive your milk supply, and how confident you feel about breastfeeding. The study is led by Marmara University in Istanbul and is currently enrolling; it does not involve drugs or medical devices.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Volunteering to participate in the study.
  • 2. Being primiparous at 24-36 weeks of pregnancy.
  • 3. To be able to speak and speak Turkish.
  • 4. To be at least a primary school graduate.
  • 5. Having a computer or smartphone at home and being able to use it.
  • 6. No risk in pregnancy.
  • 7. The woman does not have any chronic disease.
  • Exclusion Criteria:
  • 1. The emergence of a risky situation during pregnancy.
  • 2. Premature birth of the woman participating in the study.
  • 3. Carrying out a risky birth and hospitalization of the mother or baby due to it.
  • 4. Termination of pregnancy prematurely for any reason (such as infant death)
  • 5. The fact that the pregnant women in the experimental group did not complete the training modules before birth.
  • 6. The fact that the women participating in the study did not respond to the directed scales and questionnaires.
  • 7. The woman's desire to quit working without giving any reason.

About Nurdan Demirci

Nurdan Demirci is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical practices and regulatory compliance, Nurdan Demirci collaborates with leading researchers and institutions to facilitate the development of groundbreaking therapies. The organization prioritizes patient safety and engagement, ensuring that clinical trials are conducted with the highest standards of integrity and transparency. By fostering a culture of scientific excellence, Nurdan Demirci aims to contribute significantly to the healthcare landscape and address unmet medical needs.

Locations

Istanbul, Turkey

Patients applied

0 patients applied

Trial Officials

Elif velioğlu, PhDc

Principal Investigator

Marmara University

Nurdan Demirci, Prof

Study Director

Marmara University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported